Enovis Corporation (ENOV)

Market Cap	2.50B
Revenue (ttm)	2.00B
Net Income (ttm)	-119.19M
Shares Out	55.88M
EPS (ttm)	-2.18
PE Ratio	n/a
Forward PE	14.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	432,636
Open	45.07
Previous Close	45.27
Day's Range	43.22 - 45.37
52-Week Range	38.27 - 65.03
Beta	2.00
Analysts	Strong Buy
Price Target	67.44 (+50.6%)
Earnings Date	Nov 6, 2024

About ENOV

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular th...

• Industry: Specialty Industrial Machinery
• Sector: Industrials
• IPO Date: May 8, 2008
• Employees: 6,550
• Stock Exchange: NYSE
• Ticker Symbol: ENOV
• Website: https://www.enovis.com

Financial Performance

In 2023, Enovis's revenue was $1.71 billion, an increase of 9.22% compared to the previous year's $1.56 billion. Losses were -$33.26 million, 150.2% more than in 2022.

Analyst Forecast

According to 10 analysts, the average rating for ENOV stock is "Strong Buy." The 12-month stock price forecast is $67.44, which is an increase of 50.60% from the latest price.

Price Target

$67.44

(50.60% upside)

Analyst Consensus: Strong Buy